Author

Giorgia Lillo

Institution: Artios Pharma Limited (United Kingdom)

Observed institutions: Istituto Superiore di Sanità, Artios Pharma Limited (United Kingdom)

ORCID: 0009-0005-2884-0575

Observed ORCID: 0009-0005-2884-0575

OpenAlex ID: A5045929887

ATM pathway activation limits R-loop-associated genomic instability in Werner syndrome cells

2019 · Veronica Marabitti, Giorgia Lillo, et al. · Nucleic Acids Research · 81

R-Loop-Associated Genomic Instability and Implication of WRN and WRNIP1

2022 · Veronica Marabitti, Pasquale Valenzisi, et al. · International Journal of Molecular Sciences · 29

Checkpoint Defects Elicit a WRNIP1-Mediated Response to Counteract R-Loop-Associated Genomic Instability

2020 · Veronica Marabitti, Giorgia Lillo, et al. · Cancers · 26

Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types

2024 · Patrick G. Pilié, Virginia Giuliani, et al. · Clinical Cancer Research · 21

Abstract 2905: Combination of the ATR inhibitor, ART0380, with irinotecan for treating ATM-negative tumors

2025 · Helen M. Robinson, Desiree Piscitello, et al. · Cancer Research · 2

Data from Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types

2024 · Patrick G. Pilié, Virginia Giuliani, et al.

Supplementary Table S1 from Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types

2024 · Patrick G. Pilié, Virginia Giuliani, et al.

Supplementary S1-S8 from Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types

2024 · Patrick G. Pilié, Virginia Giuliani, et al.

Works count: 8

Citation count: 159

H-index: 4

I10-index: 4